News | February 16, 2022
Moderna announces expansion in key Asian markets
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
The brand is now available pan-India through their distribution partner
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
The drug will be marketed under the brand name Molnaflu
The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Subscribe To Our Newsletter & Stay Updated
